TARGET FOR IQ · CURRENT AFFAIRS
India’s TB Programme Update 2026: Mortality Estimates, Screening and Patient Support
Current affairs reading · 4 min read · English
On this page
- What is the update?
- Read the main indicators separately
- Screening activity: December 2024 to November 2026
- Reported reach and detection
- Technology and continuity of care
- Nutrition and community participation
- Mortality estimation and pending evidence
- Exam interpretation
- Exam revision
- Quick questions
- Related reading
What is the update?
A Health Ministry update on 12 November 2026 reported a 38% decline in estimated tuberculosis mortality since 2015 and a 94% treatment-success rate for drug-susceptible TB. It also described screening, diagnostic and patient-support activity under the National TB Elimination Programme. The update records progress towards elimination, not a declaration that India is TB-free.
Read the main indicators separately
| Indicator | Figure reported |
|---|---|
| Reduction in estimated TB mortality since 2015 | 38% |
| Treatment success for drug-susceptible TB | 94% |
| Programme funding requirements met domestically | 96% |
| Panchayats declared TB-free in 2025 | 67,933 |
Mortality reduction, treatment success and local TB-free declarations have different definitions and denominators. The 94% figure concerns drug-susceptible TB treatment; it should not be applied automatically to every category of TB or to all screened people.
Screening activity: December 2024 to November 2026
The first intensified 100-day campaign began on 7 December 2024 in 347 high-priority districts across 33 States and Union Territories and later expanded. A further intensive campaign began on 24 March 2026, focusing on 1.58 lakh high-risk villages and wards, congregate settings and vulnerable groups.
Reported reach and detection
| Activity through 8 November 2026 | Reported scale |
|---|---|
| People identified and brought within screening activity | More than 25 crore |
| Chest X-rays | More than 11 crore |
| Nucleic acid amplification tests | More than 3 crore |
| New TB cases identified | 48.64 lakh |
| Asymptomatic cases within identified cases | 14.97 lakh |
The asymptomatic group is included within the total identified cases, not an extra number to add. Screening reach, number of tests and diagnosed cases also measure different stages, and repeated tests can occur. Finding more cases through active screening does not by itself prove that underlying disease incidence has increased.
Technology and continuity of care
The programme uses portable digital X-rays, AI-supported screening and rapid molecular diagnostics. Ni-kshay supports patient records, treatment monitoring and programme management. The update also describes integrating care with attention to diabetes, undernutrition and other conditions.
Digital tools can assist screening and follow-up, but a population-level programme update is not a basis for self-diagnosis or treatment selection. The article concerns health policy and surveillance rather than individual clinical advice.
Nutrition and community participation
Ni-kshay Poshan Yojana provides eligible patients with financial assistance for nutritional needs during treatment. Ni-kshay Mitra mobilises people and institutions to offer nutritional and psychosocial support. These are distinct mechanisms within the broader response.
The update describes JOSH teams at block and ward levels, led by designated Class-I officers and supported by five NCC cadets and five MY Bharat volunteers. Their roles concern awareness, outreach and community mobilisation.
Mortality estimation and pending evidence
The ministry’s account of the WHO Global Tuberculosis Report 2026 refers to evidence from the Sample Registration System, verbal-autopsy assessments and Ni-kshay programme data. It gives rounded mortality rates of 28 per lakh in 2015 and 18 per lakh in 2025 alongside the reported 38% reduction. The stated percentage should not be reconstructed as an exact calculation from rounded endpoints.
A nationally representative 2025 prevalence survey by ICMR–National Institute for Research in Tuberculosis had been shared with WHO and remained under technical discussion. An updated country profile was expected after that process. This distinction matters: evidence still being reviewed should not be represented as an already final revised estimate.
Exam interpretation
Use the update to distinguish incidence, mortality, screening, notification and treatment outcomes. A strong public-health answer explains why earlier detection, effective treatment, nutrition and follow-up work together, while acknowledging that progress indicators do not equal nationwide elimination.
Exam revision
- Ministry update: 12 November 2026.
- Reported mortality reduction since 2015: 38%.
- Treatment success: 94% for drug-susceptible TB.
- 48.64 lakh cases identified in the stated campaign window, including 14.97 lakh asymptomatic cases.
- Prevalence-survey evidence was still under technical discussion for an updated profile.
Quick questions
Does the update declare India TB-free?
No. It reports progress and continuing work towards elimination.
Should asymptomatic cases be added again to the total identified cases?
No. They are a subset of the 48.64 lakh identified cases reported.
Official references: Ministry of Health and Family Welfare — 2026-11-12.